Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937)
- PMID: 1724875
Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937)
Abstract
The inhibitory effect of azidothymidine (AZT) on HIV replication in the promonocytic cell line U937 was investigated. After infection with HIV-1/LAV virus, U937 cells were cultured for prolonged period in the presence of the drug at a final concentrations of 20 mumol/l or 50 mumol/l, respectively. The antiviral activity was determined according to the inhibition of viral reverse transcriptase activity, and of viral antigen production (immunofluorescence assay). We conclude that virus production was not efficiently influenced during long term passage even at high drug concentrations.
Similar articles
-
Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.Virology. 2001 May 10;283(2):294-305. doi: 10.1006/viro.2001.0888. Virology. 2001. PMID: 11336554
-
Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro.Biochem Biophys Res Commun. 1994 Jun 30;201(3):1424-32. doi: 10.1006/bbrc.1994.1862. Biochem Biophys Res Commun. 1994. PMID: 8024587
-
Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.Mol Pharmacol. 1995 Jul;48(1):15-20. Mol Pharmacol. 1995. PMID: 7542738
-
Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.Mol Pharmacol. 2000 Nov;58(5):1100-8. Mol Pharmacol. 2000. PMID: 11040059
-
Update on antiretroviral agents other than zidovudine.AIDS. 1989;3 Suppl 1:S145-51. doi: 10.1097/00002030-198901001-00022. AIDS. 1989. PMID: 2482054 Review. No abstract available.